Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20170216Phase 2Completed
A Phase 2 trial of zanubrutinib in hepatocellular carcinoma (HCC), sponsored by Zai Lab. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20170216.